SLC5A2 and metabolic dysfunction-associated steatotic liver disease: Although the data must be corroborated, it is paradigmatic that the main measures aimed at containing and countering the progression of NAFLD, such as calorie restriction, exercise, use of metformin, GLP-1 receptor agonists, SGLT2 inhibitors, act on important autophagy targets [27,28,29,30] (Figure 1).